Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment

Virology

Volumn 275, Issue 1, 2000, Pages 98-106

  Tovar Sepulveda, VerÜnica A ^a   Berdel, Bianca ^a   Coffin, John M ^b   Reuss, Frank U ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYBRID PROTEIN; LUCIFERASE; MESSENGER RNA; SUPERANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE;

ANIMALIA; DNA VIRUSES; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE; RNA VIRUSES; TUMOR VIRUS;

EID: 0034665222     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0491     Document Type: Article

References (39)

1. Superantigens of mouse mammary tumor virus
2. Promoter occlusion: Transcription through a promoter may inhibit its activity
3. Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain
4. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens
5. Some possible effects of nursing on the mammary gland tumor incidence in mice
6. Structure and biological activity of the subgenomic Mtv-6 endogenous provirus
7. Molecular cloning and sequencing of the MTV-1 LTR: Evidence for a LTR sequence alteration
8. Growth of factor-independent hemopoietic precursor cell lines
9. Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene
10. Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyridine-stimulated mammary tumor cell cultures
11. Linkage of MIs genes to endogenous mammary tumor viruses of inbred mice
12. Isolation and characterization of full-length cDNA clones for human α, β and γ-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cystein that is subsequently removed
13. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat
14. Natural infection of Swiss mice with mouse mammary tumor virus (MMTV): Viral expression in milk and transmission of infection
15. Superantigen-reactive CD4+ T ceils are required to stimulate B cells after infection with mouse mammary tumor virus
16. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission
17. Self-tolerance eliminates T cells specific for MIs-modified products of the major histocompatibility complex
18. Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation through distinct regulatory pathways
19. Direct detection of exogenous mouse mammary tumor virus sequences in lymphoid cells of BALB/ cfC3H female mice
20. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage
21. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene
22. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene
23. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: Two frameshift suppression events are required for translation of gag and pol
24. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
25. Mammary neoplasia in mice
26. II-3-dependent mouse clones that express B-220 surface antigen, contain lg genes in germ-line configuration, and generate B lymphocytes in vivo
27. Identification of the region of T cell receptor beta chain that interacts with the self-superantigen MIs-1a
28. Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation
29. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer
30. Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene
31. Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: Increased rate of synthesis of viral RNA
32. Dexamethasone induction of the intracellular RNAs of mouse mammary tumor virus
33. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector
34. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus
35. Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA
36. Transcription of mouse mammarytumor virus: Identification of a candidate mRNA for the long terminal repeat gene product
37. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene
38. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region